Sridhar Kosaraju
Direttore/Membro del Consiglio presso 10X GENOMICS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Sridhar Kosaraju
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| 10X GENOMICS, INC. | Direttore/Membro del Consiglio | 01/03/2019 | - |
| Independent Dir/Board Member | 01/03/2019 | - | |
| NEVRO CORP. | Direttore/Membro del Consiglio | 31/08/2021 | - |
| Independent Dir/Board Member | 31/08/2021 | - | |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Direttore/Membro del Consiglio | 27/10/2020 | - |
| Amministratore Delegato | 27/10/2020 | - | |
| Presidente | 27/10/2020 | - | |
| Testing For America | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Sridhar Kosaraju
Precedenti posizioni note di Sridhar Kosaraju
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PENUMBRA, INC. | Direttore Finanziario/CFO | 01/05/2015 | 01/11/2019 |
| Presidente | 29/08/2019 | 12/05/2020 | |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/01/1999 | 01/05/2015 |
Formazione di Sridhar Kosaraju
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Director/Board Member | 4 |
| President | 2 |
| Independent Dir/Board Member | 2 |
Settori
| Health Technology | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PENUMBRA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| NEVRO CORP. | Health Technology |
| Aziende private | 3 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
| Testing For America |
- Borsa valori
- Insiders
- Sridhar Kosaraju
- Esperienza
